News | May 22, 2009

CPC Files Patent for Synthetic Vascular Closure Sealant

May 22, 2009 - CPC of America Inc. filed its first patent of a synthetic sealant for the MedClose Vascular Closure System (VCS), which is an internal puncture-closing system for use in percutaneous intravascular diagnostic and interventional procedures.

The company plans to file patents for more intellectual properties for formulations of synthetic sealants in the MedClose VCS vascular closure product line, which initially will be designed for use with 6-9 Fr. applications.

The MedClose VCS device consists of two parts - a delivery system to release the sealant to the puncture site and the synthetic sealant itself.

The sealing compound is currently undergoing tests in animals. The company said the animal testing to date is not conclusive, but it is pleased with the preliminary results. The company hopes the development of the sealant will resolve outstanding issues with the FDA concerning the company’s application for an investigational device exemption.

For more information: www.cpcmeddevices.com

Related Content

The FDA’s market clearance occurred once the agency reviewed EnsiteVascular’s Section 510(k) premarket notification of intent to market the SiteSeal SV device and determined it is substantially equivalent for the indication for use stated: brachial artery closure. Previously, EnsiteVascular received FDA market clearance for SiteSeal SV for radial artery closure.
News | Hemostasis Management | April 21, 2021
April 21, 2021 — EnsiteVascular announced it received its second U.S.
The Teleflex Manta large-bore vascular closure device can seal holes between 12 and 25 French.

The Teleflex Manta large-bore vascular closure device can seal holes between 12 and 25 French. 

Feature | Hemostasis Management | March 09, 2021 | Dave Fornell, Editor
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these tra
Teleflex Acquires Hemostatic Products Vendor Z-Medica
News | Hemostasis Management | February 08, 2021
February 8, 2021 — Teleflex Inc.
Merit Medical Launches PreludeSync Evo Radial Compression Device
News | Hemostasis Management | August 29, 2019
Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial compression device. The...
PreludeSync Distal Compression Device Available Globally
Technology | Hemostasis Management | February 01, 2019
Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available in the United...
nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management | August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
News | Hemostasis Management | January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...